Literature DB >> 17047376

The cost of medical care for the acromegalic patient.

Robert Knutzen1, Shereen Ezzat.   

Abstract

Despite ample proof to the contrary, the overwhelming number of health care practitioners still believe that acromegaly is a disease that they will rarely encounter, let alone have to treat. However, the reality is quite a bit different for both doctors and patients. Many of the obvious symptoms and signs of this disease manifest slowly and insidiously. As such, the majority of patients are often treated for seemingly unrelated conditions for years before the actual diagnosis of acromegaly is established. Thus, the overall cost of medical care for the acromegalic patient is considerably higher than appreciated at first glance. The financial cost of managing this disease must include the cost of care of comorbid conditions before and following the diagnosis of acromegaly. It is only through a higher degree of awareness that this disease will be identified earlier in its course and the true number of acromegalic patients is realized. We anticipate that such measures will serve to limit the psychological, emotional and economic burden of this potentially debilitating disease.

Entities:  

Mesh:

Year:  2006        PMID: 17047376     DOI: 10.1159/000095521

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  5 in total

1.  Cost of clinical management of acromegaly in Spain.

Authors:  Montse Roset; Sandra Merino-Montero; Manuel Luque-Ramírez; Susan M Webb; Pedro López-Mondéjar; Isabel Salinas; Alfonso Soto; Carmen Bernal; Carlos Villabona; Daniel De Luis; Sergio Donnay; Herminia Pascual; Jesús Pérez-Luis
Journal:  Clin Drug Investig       Date:  2012-04-01       Impact factor: 2.859

2.  Treatments, complications, and healthcare utilization associated with acromegaly: a study in two large United States databases.

Authors:  M S Broder; M P Neary; E Chang; D Cherepanov; L Katznelson
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

Review 3.  A practical approach to acromegaly management in Latin America.

Authors:  Marcello D Bronstein; Oscar D Bruno; Alin Abreu; Ruth Mangupli; Moisés Mercado
Journal:  Pituitary       Date:  2014-01       Impact factor: 4.107

4.  Pharmacoeconomic aspects of the treatment of pituitary gland tumours.

Authors:  Jerzy Sowiński; Nadia Sawicka; Katarzyna Piątek; Ariadna Zybek; Marek Ruchała
Journal:  Contemp Oncol (Pozn)       Date:  2013-04-29

5.  [Selective screening of patients with associated somatic diseases as a method of early detection of acromegaly].

Authors:  M B Antsiferov; V S Pronin; T M Alekseeva; O A Ionova; E Y Martynova; Yu E Poteshkin; N A Chubrova; K Y Zherebchikova
Journal:  Probl Endokrinol (Mosk)       Date:  2021-01-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.